logo/base Created with Sketch.

Search results for “”

Press Release
28.05.2024
Transforming Liver Health: Echosens Next-Generation FibroScan® Now Available Worldwide
chevron
page
Liver Health Management - Join the waiting list
chevron
Article
25.04.2024
Echosens statement on the passing of Dr. Stephen Harrison
chevron
Article
18.04.2024
Revolutionizing Liver Disease Treatment: A Conversation with Dr. Naim Alkhouri about the First-ever Therapeutic for MASH
chevron
page
White Paper - The Technology Behind Guided VCTE™
chevron
Article
15.04.2024
Join us on World Liver Day 2024
chevron
page
WHO Guidelines on CHB infection - 2024
chevron
Press Release
27.03.2024
Welcome Prof. Victor de Lédinghen MD PhD, Our New Chief Medical Officer at Echosens
chevron
Podcast
25.03.2024
Beyond Biopsies: The Revolution of Liver Health with FibroScan®
chevron
page
Liver Health Super Shaper Award
chevron
Webinar
18.03.2024
Using VCTE™ on Patients with Fatty Liver in the Endocrinology Setting
chevron
products
Guided VCTE™
chevron
Article
09.10.2023
Turning Point report recommends using FibroScan®
chevron
page
Search
chevron
Webinar
04.09.2023
Empowering Care in Bariatric and Metabolic Surgery
chevron
Article
04.09.2023
Understanding the Nomenclature Shift in Fatty Liver Disease
chevron
Webinar
12.06.2023
Diagnosis and Management of MAFLD Patients
chevron
Article
07.06.2023
NICE Issues Landmark Guidance to Bring Routine Liver Scans to Primary Care Settings
chevron
Article
24.05.2023
Symposium at ILC 2023 with Novo Nordisk
chevron
Article
01.05.2023
Hepatitis Awareness Month
chevron
Webinar
26.04.2023
Understanding the Role of Elastography for Management of Pediatric Liver Disease
chevron
Article
18.04.2023
Liver Health Experts and Echosens Technology Featured on eHealth Radio Network
chevron
Press Release
23.03.2023
FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management
chevron
Webinar
16.03.2023
Leveraging ​​​FibroScan® Solutions in Clinical Trials
chevron
Webinar
10.03.2023
FibroScan® Included in Key International Guidelines
chevron
Article
01.03.2023
March is the American National Nutrition Month
chevron
page
AASLD Practice Guidance - 2023 update
chevron
Webinar
15.02.2023
NASH Club 2023, a series of 3 educational CME accredited HCPs program
chevron
Press Release
13.02.2023
New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH
chevron
page
Do you need a liver examination?
chevron
page
Test your eligibility for FibroScan® GO
chevron
page
Trademarks
chevron
Article
18.01.2023
We are shaping the future of liver health- Laurent Sandrin on CNEWS
chevron
page
Environmental, Social and Governance
chevron
Article
02.11.2022
Addressing Link Between Obesity and Non-Alcoholic Fatty Liver Disease: New SmartExam Technology Extends Use of FibroScan® Among Severely Obese Patients
chevron
Webinar
02.11.2022
Understanding New FibroScan® Software Enhancements Which Optimize Overweight Patient Testing
chevron
page
White Paper - The Role of FibroScan and Associated Solutions in MASH Clinical Trials
chevron
Article
18.10.2022
Echosens Urges Increased Screening, Detection and Monitoring of Liver Health during October Liver Cancer Awareness Month
chevron
page
International Guidelines
chevron
Webinar
21.09.2022
Examination with FibroScan®: Why do it in Primary Care?
chevron
Article
17.08.2022
Upcoming National Health Center Week Showcases Leaders in Preventative Medicine and Early Detection
chevron
products
FibroView™ Report
chevron
Article
26.07.2022
Halting Hepatitis: One of the World's Major Public Health Crises
chevron
Webinar
01.07.2022
FibroScan® Solutions Bringing New Guidelines to Life
chevron
Press Release
23.06.2022
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
chevron
Article
22.06.2022
Rate of Body Mass Index Increase Doubled Among Pediatric Patients During COVID-19 Pandemic
chevron
Webinar
15.06.2022
NIT-Based NAFLD Identification –
Understanding the New AGA Clinical Care Pathway
chevron
page
AACE Clinical Practice Guidelines 2022 AASLD
chevron
Article
31.05.2022
June 2022 is Liver Health Matters Month
chevron
Webinar
24.05.2022
Improving Management of Patients with Advanced Liver Disease Through Liver and Spleen Stiffness Assessment
chevron
Article
19.04.2022
World Liver Day - April 19th 2022
chevron
Article
04.04.2022
April is the American Alcohol Awareness Month
chevron
Article
01.04.2022
April is the American Minority Health Month
chevron
Webinar
22.03.2022
Current Perspectives in NAFLD-NASH Identification & Management – A Diabetologist’s Perspective
chevron
Article
21.03.2022
American National Drug and Alcohol Facts Week: Raising Awareness About the Link Between Alcohol and Liver Disease
chevron
products
FibroScan® GO
chevron
Article
10.02.2022
New Baveno VII Guidelines Further Validate FibroScan® for Management of Patients with Advanced Chronic Liver Disease
chevron
page
Baveno VII Renewing Consensus - Update 2021
chevron
Article
01.02.2022
American Heart Month: Battling the Epidemics of Cardiovascular Disease and Liver Disease
chevron
Press Release
15.12.2021
Innovative New Products and Technology Advancing Worldwide Liver Disease Management Highlight Echosens 20th Anniversary
chevron
Webinar
24.11.2021
AASLD Wrap Up; Key Lessons in NAFLD NASH Diagnostic Strategies
chevron
Article
24.11.2021
Highlights from 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan® Mitigates Risk of Patients Developing Fibrosis/Cirrhosis
chevron
Article
02.11.2021
Non-Invasive Point-of-Care Exam Helps Battle Liver Disease in Individuals with Obesity
chevron
White Paper
27.10.2021
Independent Study Shows FibroScan® Technology Offers Payers Positive Return on Investment
chevron
page
White Paper: Using FibroScan® Technology Offers Payers Cost Savings
chevron
Article
01.10.2021
Link Between Non-alcoholic Fatty Liver Disease, Obesity and Liver Cancer Calls for Early Detection and Monitoring
chevron
White Paper
14.09.2021
Impact of Obesity in Nonalcoholic Fatty Liver Disease & Metabolic Syndrome
chevron
page
White Paper: Diet Metabolic Syndrome
chevron
Article
12.08.2021
New EASL Clinical Practice Guidelines Make Unprecedented Recommendation for Non-Invasive FibroScan® and Care Management
chevron
Press Release
09.08.2021
Echosens Highlights New EASL Clinical Practice Guidelines
chevron
Article
03.08.2021
Douglas Dieterich, M.D., discusses role of FibroScan® in the diagnoses of chronic liver disease
chevron
Article
28.07.2021
Non-Invasive Liver Exam Identifies Asymptomatic Liver Disease, Provides Follow-Up for Hepatitis C Virus
chevron
Article
26.07.2021
NICE Experts Endorse FibroScan®: Cost-Effective Liver Exam
chevron
Article
26.07.2021
Lancet Study: FibroScan® Identifies Severe Fibrosis/Cirrhosis for Earlier Diagnosis
chevron
Article
23.07.2021
Population-Based Return on Investment of Deploying Transient Elastography
chevron
Article
09.07.2021
Echosens CEO Discusses How Company Helps Fight Liver Disease Epidemic
chevron
Webinar
05.07.2021
Enhancing the management of NAFLD patients with FibroScan®-based scores
chevron
page
EASL Clinical Practice Guidelines – 2021 update
chevron
Press Release
24.06.2021
Leading Liver Disease Researchers Present at EASL International Liver Congress™ 2021
chevron
Article
21.06.2021
Celebrating 2 decades of liver health
chevron
page
Contact Support
chevron
Press Release
09.06.2021
Echosens Launches New FibroScan®-based Scores Agile 3+ & Agile 4
chevron
Article
31.05.2021
Help Support First Annual Liver Health Matters Month!
chevron
Article
27.05.2021
Research Featured as Cover Story in April Issue of Clinical Gastroenterology & Hepatology Demonstrates FibroScan®’s Ability to Monitor Liver-related Events and Survival
chevron
Article Webinar
26.05.2021
GI Practice Profitability Enhanced by Addition of Obesity & Fatty Liver Chronic Care Management Services
chevron
Article
12.05.2021
Dr. Stephen Harrison Discusses Clinical Importance of FibroScan® Technology
chevron
products
Agile 4
chevron
products
Agile 3+
chevron
Article
22.04.2021
FibroScan® 630 Expert: Complete, Non-invasive Solution Offers Effective Management and Risk Stratification for Patients with Cirrhosis and Portal Hypertension
chevron
Webinar
10.04.2021
Strategies For Identification of NAFLD NASH in T2DM Using Non Invasive Diagnostic Tools
chevron
Article
10.04.2021
Type 2 diabetes: search for « fatty liver »
chevron
Article
10.04.2021
Interest of a liver exploration for an early diagnosis of NASH
chevron
Article
10.04.2021
FibroScan® and the role of liver stiffness
chevron
Article
10.04.2021
VCTE™& elastography
chevron
Webinar
10.04.2021
Spleen Stiffness - The Noninvasive Alternative For Assessment of Portal Hypertension & Esophageal Varices Risk
chevron
Article
09.04.2021
COVID-19 Impact: Higher Risks of Severity Among Obese and Chronic Liver Disease Patients
chevron
Article
09.04.2021
FibroScan® Recommended for Hepatitis C Patients
chevron
Article
09.04.2021
Echosens Observes National Drug and Alcohol Facts Week 2021
chevron
Article
09.04.2021
Economic Analysis Model Suggests Screening People for Fibrosis With Non-Invasive Tests Cost-effective
chevron
Press Release
09.04.2021
International NASH Day 2020
chevron
Article
09.04.2021
Innovative FAST™ Score Helps Clinicians Address the Epidemic of Active Fibrotic NASH
chevron
Article
09.04.2021
Echosens Takes a Proactive Leadership Position
chevron
Article
09.04.2021
HCV Treatments Can Cure Viral Infection, Not Neccessarily Liver Disease
chevron
Article
09.04.2021
Answering the worldwide need for chronic liver disease assessment and diagnosis
chevron
White Paper
09.04.2021
Looming Epidemic: Non-Alcoholic Fatty Liver Disease
chevron
Press Release
09.04.2021
Echosens Appoints Dominique Legros as Group CEO
chevron
White Paper
09.04.2021
Fatty Liver in Hepatitis C Patients
chevron
Press Release
09.04.2021
Echosens & NASHNet Recognize International NASH Day
chevron
Article
09.04.2021
Follow-up of cirrhotic patients after etiologic treatment
chevron
Webinar
09.04.2021
Understanding the Place of Non-Invasive Testing in the Management of Chronic Hepatitis C
chevron
Webinar
09.04.2021
AASLD 2020 Update
chevron
Webinar
09.04.2021
Place of FibroScan® in the management of patients with alcohol use disorders
chevron
Webinar
09.04.2021
FibroScan® and Fast™ score: Game Changers in Staging NAFLD and Assessing Treatment Response
chevron
Webinar
09.04.2021
2020 EASL UPDATE
chevron
Webinar
09.04.2021
Obesity and Fatty Liver Disease: Twin Epidemics
chevron
Press Release
09.04.2021
Echosens and NASHNET recognize International NASH DAY
chevron
Press Release
09.04.2021
NICE issues briefing on FibroScan® liver exam
chevron
Press Release
09.04.2021
World Diabetes Day 2020
chevron
page
Bibliography
chevron
products
SmartExam
chevron
products
FibroScan® Mini 430
chevron
page
interview Stephen Harrison
chevron
page
interview Frias
chevron
page
interview Douglas Dieterich
chevron
page
interview Stephen Esposito
chevron
page
Probe and machine disinfection
chevron
page
Laurent’s story
chevron
page
HCV HBV
chevron
page
Alcoholic liver disease
chevron
page
Patents
chevron
page
Clinical Trials
chevron
page
Services
chevron
page
Clinical Evidences - Archive
chevron
page
Clinical Library
chevron
products
myFibroScan
chevron
products
Liver Health Management
chevron
products
Fast™
chevron
products
FibroScan® Probes
chevron
products
FibroScan® Gateway
chevron
products
CAP™ module
chevron
products
FibroScan® Mini+ 430
chevron
products
FibroScan® Compact 530
chevron
products
FibroScan® Expert 630
chevron
page
Blog and news
chevron
page
Privacy notice
chevron
page
Legal notice
chevron
page
Contact
chevron
page
General Terms and Conditions of Sale
chevron
page
Covid FAQs
chevron
page
Users testimonials
chevron
page
Recommendations
chevron
page
Locate us
chevron
page
Spontaneous application form
chevron
page
Working at Echosens
chevron
page
Find a FibroScan® near you
chevron
page
Information for patients
chevron
page
MASLD / MASH
chevron
page
Clinical Evidences
chevron
page
About us
chevron
page
Users
chevron
page
Liver health
chevron
page
Scores by echosens
chevron
page
FibroScan® by echosens
chevron
page
Home
chevron